These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5126382)

  • 21. Activity of coagulation and fibrinolysis parameters in animals.
    Karges HE; Funk KA; Ronneberger H
    Arzneimittelforschung; 1994 Jun; 44(6):793-7. PubMed ID: 8053983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin-dependent spleen transamidase.
    Zuch A
    Haemostasis; 1980; 9(2):85-91. PubMed ID: 6102074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation.
    Richardson VR; Schroeder V; Grant PJ; Standeven KF; Carter AM
    Br J Haematol; 2013 Jan; 160(1):116-9. PubMed ID: 23078103
    [No Abstract]   [Full Text] [Related]  

  • 24. [Desmofibrinogenic activity of transamidases and thiol groups in plasma and tissues after aflatoxin B poisoning].
    Zuch A; Januszko T; Popławska T
    Pol Arch Med Wewn; 1978 Feb; 59(2):171-81. PubMed ID: 643693
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the influence of natural and synthetic antifibrinolytic agents on the determination of the fibrin stabilizing factor (factor 13)].
    Vogel G; Sundermann A; König B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):179-81. PubMed ID: 4174656
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of cysteine and hemolyzed erythrocytes on the properties of clotted fibrin.
    Ostrowski L
    Pol Med J; 1966; 5(6):1197-214. PubMed ID: 5973024
    [No Abstract]   [Full Text] [Related]  

  • 27. [Wound healing disorders caused by coexistence of plasma transaminase and thiol group deficiency].
    Zuch A; Pietruska Z; Bogdanikowa B; Chwal Z
    Pol Arch Med Wewn; 1973 Apr; 50(4):399-403. PubMed ID: 4702961
    [No Abstract]   [Full Text] [Related]  

  • 28. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of fibrin stabilizing factor (FSF) in thrombocytopenia in childhood.
    Ströder J
    Ann Paediatr; 1965; 205(6):438-41. PubMed ID: 5898747
    [No Abstract]   [Full Text] [Related]  

  • 30. PLASMA FIBRIN STABILIZING FACTOR ACTIVITY IN VARIOUS DISEASES.
    NUSSBAUM M; MORSE BS
    Blood; 1964 May; 23():669-78. PubMed ID: 14142505
    [No Abstract]   [Full Text] [Related]  

  • 31. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the endothelium in the control of vascular smooth muscle function.
    Vanhoutte PM; Rimele TJ
    J Physiol (Paris); 1982-1983; 78(7):681-6. PubMed ID: 6764647
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetics of transamidating enzymes. Production of thiol in the reactions of thiol esters with fibrinoligase.
    Curtis CG; Stenberg P; Brown KL; Baron A; Chen K; Gray A; Simpson I; Lorand L
    Biochemistry; 1974 Jul; 13(16):3257-62. PubMed ID: 4841063
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of procoagulants and anticoagulants in the development of venous thromboembolism.
    Bertina RM
    Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of the fibrinogen gamma' chain: implications for the binding of factor XIII, thrombin and platelets.
    Doolittle RF; Hong S; Wilcox D
    J Thromb Haemost; 2009 Aug; 7(8):1431-3. PubMed ID: 19552683
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrin sealants in supporting surgical techniques: strength in factor XIII.
    Phillips M; Dickneite G; Metzner H
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():13-6. PubMed ID: 12869983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrin assembly.
    Hantgan R; McDonagh J; Hermans J
    Ann N Y Acad Sci; 1983 Jun; 408():344-66. PubMed ID: 6135380
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of functional human coagulation factor XIII A-domain in plant cell suspensions and whole plants.
    Gao J; Hooker BS; Anderson DB
    Protein Expr Purif; 2004 Sep; 37(1):89-96. PubMed ID: 15294285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [THE FIBRIN-STABILIZING FACTOR].
    GORMSEN J
    Ugeskr Laeger; 1964 Oct; 126():1417-22. PubMed ID: 14240318
    [No Abstract]   [Full Text] [Related]  

  • 40. [The significance of changes in the functional properties of blood platelets, factor XIII activity and fibrin clot quality in the pathogenesis of hemorrhagic diathesis secondary to experimental vitamin C deficiency].
    Sushkevich GN; Khnychev SS; Oĭvin VI
    Vopr Pitan; 1969; 28(5):23-7. PubMed ID: 5370913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.